Net Income (Loss) Per Common Share

9 Months Ended

Aug. 31, 2014

Earnings Per Share [Abstract]

Net Income (Loss) Per Common Share

Note 5 – Net Income (Loss) Per Common Share

Basic net income (loss) per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of vested, common shares outstanding during the period (denominator). Diluted net income (loss) per share is computed on the basis of the weighted average number of shares of common stock outstanding plus the effect of dilutive potential common shares outstanding during the period using the if-converted method. Dilutive potential common shares include shares issuable upon exercise of outstanding stock options, warrants and convertible debt agreements.

	Nine months ended August 31,					Three months ended August 31,
	2014			2013		2014			2013
Net income (loss) - basic	$	(439,397	)	$	656,655	$	(97,112	)	$	(1,019,151	)
Interest expense – convertible notes		—			385,944		—			—
Net income (loss) - diluted	$	(439,937	)	$	1,042,479	$	(97,112	)	$	(1,019,151	)
Weighted average common shares outstanding - basic		967,371,815			556,328,538		1,007,549,997			729,759,164
Effect of dilutive securities		—			686,887,497		—			—
Weighted average common shares outstanding – diluted		967,371,815			1,243,216,035		1,007,549,997			729,759,164
Earnings (loss) per common share - basic	$	(0.00	)	$	0.00	$	(0.00	)	$	(0.00	)
Earnings (loss) per common share - diluted	$	(0.00	)	$	0.00	$	(0.00	)	$	(0.00	)

Approximately 9,540,651,000 shares of common stock issuable upon the exercise of our outstanding stock options, warrants or convertible debt were excluded from the calculation of net income (loss) per share for the nine-month period ended August 31, 2014 because the effect would be anti-dilutive. Approximately 9,540,651,000 shares and 10,165,000 shares of common stock issuable upon the exercise of our outstanding stock options, warrants or convertible debt were excluded from the calculation of net income (loss) per share for the three-month periods ended August 31, 2014 and 2013, respectively, because the effect would be anti-dilutive.